Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
复制标题
DOI:
10.1016/j.cell.2014.09.051
复制
发表时间:
2014-10-23
期刊:
影响因子:
64.5
通讯作者:
Minn AJ
中科院分区:
文献类型:
--
作者:
Boelens MC;Wu TJ;Nabet BY;Xu B;Qiu Y;Yoon T;Azzam DJ;Twyman-Saint Victor C;Wiemann BZ;Ishwaran H;Ter Brugge PJ;Jonkers J;Slingerland J;Minn AJ
Stromal communication with cancer cells can influence treatment response. We show that stromal and breast cancer (BrCa) cells utilize paracrine and juxtacrine signaling to drive chemotherapy and radiation resistance. Upon heterotypic interaction, exosomes are transferred from stromal to BrCa cells. RNA within exosomes, which are largely non-coding transcripts and transposable elements, stimulates the pattern recognition receptor RIG-I to activate STAT1-dependent anti-viral signaling. In parallel, stromal cells also activate NOTCH3 on BrCa cells. The paracrine anti-viral and juxtacrine NOTCH3 pathways converge as STAT1 facilitates transcriptional responses to NOTCH3 and expands therapy resistant tumor-initiating cells. Primary human and/or mouse BrCa analysis support the role of anti-viral/NOTCH3 pathways in NOTCH signaling and stroma-mediated resistance, which is abrogated by combination therapy with gamma secretase inhibitors. Thus, stromal cells orchestrate an intricate cross-talk with BrCa cells by utilizing exosomes to instigate anti-viral signaling. This expands BrCa subpopulations adept at resisting therapy and re-initiating tumor growth.
登录
查看更多内容
影响因子:
32.4
作者:
Loo YM;Gale M Jr
通讯作者:
Gale M Jr
影响因子:
14.5
作者:
Belancio VP;Roy-Engel AM;Deininger PL
通讯作者:
Deininger PL
影响因子:
4.4
作者:
Chen, Xi;Ishwaran, Hemant
通讯作者:
Ishwaran, Hemant
DOI:
10.1073/pnas.1209414109
发表时间:
2012-07-31
影响因子:
11.1
作者:
Fabbri, Muller;Paone, Alessio;Croce, Carlo M.
通讯作者:
Croce, Carlo M.
影响因子:
64.5
作者:
Luga, Valbona;Zhang, Liang;Wrana, Jeffrey L.
通讯作者:
Wrana, Jeffrey L.